Poster Presentation Sydney Spinal Symposium 2026

Diffusion Tensor Imaging in Degenerative Cervical Myelopathy: Clinical Translation Opportunities for Cause of Pain Detection and Potentially Early Diagnoses (#103)

Suhani SS Sharma 1 , Alisha AS Sial 1 2 , Georgia GB Bright 3 4 , Ryan ROD O'Hare Doig 4 5 , Ashish AD Diwan 1 2 6
  1. Spine Labs, University of New South Wales, Sydney , NSW , Australia
  2. Spine Service, Department of Orthopaedics, University of New South Wales , Sydney, NSW, Australia
  3. School of Biomedicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide , South Australia , Australia
  4. Neil Sachse Centre for Spinal Cord Research, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
  5. Adelaide Medical School, , University of Adelaide, Adelaide , South Australia, Australia
  6. Spinal Unit, Discipline of Orthopaedic Surgery, Royal Adelaide Hospital, Adelaide , South Australia, Australia

Degenerative cervical myelopathy (DCM) is a common cause of spinal cord dysfunction in adults and is frequently accompanied by pain, a symptom that remains under-recognised despite its profound impact on quality of life. Conventional magnetic resonance imaging (MRI) is indispensable for identifying structural spinal cord compression; however, it is unable to detect early microstructural alterations, particularly those that may contribute to pain pathophysiology. This narrative review critically appraises the limitations of standard MRI in the diagnostic assessment of DCM and examines the expanding role of advanced imaging modalities—most notably diffusion tensor imaging (DTI)—in evaluating spinal cord integrity. DTI-derived parameters, including fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD), demonstrate sensitivity to axonal and myelin injury. For example, reductions in FA and AD have been linked to axonal disruption in sensory pathways, while elevations in RD suggest demyelination, a hallmark of neuropathic pain. Despite this potential, the widespread implementation of DTI is constrained by technical heterogeneity, limited accessibility, and the absence of standardised protocols. Future research priorities include the incorporation of pain-specific imaging endpoints, longitudinal validation across diverse cohorts, and integration with artificial intelligence frameworks to enable automated analysis and predictive modelling. Collectively, these advances hold promise for enabling earlier diagnosis, refined symptom stratification, and more personalised therapeutic strategies in DCM.